{"gene":"KLRC2","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1997,"finding":"NKG2C delivers an activating signal in NK cells: chimeric receptor constructs (NKG2C/NKR-P1C) stimulated lytic activity and calcium mobilization in RNK-16 cells, while SHP-1 did not associate with the NKG2C cytoplasmic domain (unlike the inhibitory NKG2A), establishing NKG2C as an activating receptor.","method":"Chimeric receptor transfection in rat NK cell line, cytolytic assay, calcium mobilization, immunoprecipitation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with chimeric receptors, functional assays, and co-immunoprecipitation in single rigorous study","pmids":["9103421"],"is_preprint":false},{"year":1998,"finding":"CD94/NKG2C forms a non-covalent complex with DAP12 (an ITAM-bearing adaptor), and charged residues in the transmembrane domains of both DAP12 and NKG2C are required for this interaction and for efficient surface expression of the receptor.","method":"Co-immunoprecipitation, surface expression analysis, transmembrane domain mutagenesis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis and co-IP identifying the molecular basis of receptor assembly","pmids":["9655483"],"is_preprint":false},{"year":1998,"finding":"NKG2C (Kp39) covalently associates with CD94 to form an activating receptor complex on a subset of NKG2A-negative NK cells; cytolytic activity of NKG2A−P25+ NK clones can be triggered by an NKG2C-specific mAb in redirected killing, and biochemical analysis of COS7 cells co-transfected with CD94 and NKG2C confirmed the identity of Kp39 as NKG2C.","method":"Immunoprecipitation, peptide mapping, RT-PCR, COS7 co-transfection, redirected killing assay","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution plus functional killing assay, multiple orthogonal methods","pmids":["9485212"],"is_preprint":false},{"year":1999,"finding":"CD94/NKG2C binds HLA-E in a peptide-dependent manner; the activating CD94/NKG2C receptor has a lower binding affinity for HLA-E than the inhibitory CD94/NKG2A receptor, with very fast association and dissociation kinetics, and the affinity of peptide-HLA-E complexes correlates with NK cell response.","method":"Surface plasmon resonance (kinetic binding analysis) with soluble recombinant HLA-E and soluble CD94/NKG2C proteins, peptide-dependent assembly","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding assay with recombinant proteins, quantitative kinetics, peptide dependency established","pmids":["10428963"],"is_preprint":false},{"year":1999,"finding":"Mouse CD94/NKG2C (and CD94/NKG2E) bind to the non-classical MHC class Ib molecule Qa-1b, the mouse functional counterpart of HLA-E, and these receptors likely function as activating receptors based on cytoplasmic domain features distinct from inhibitory NKG2A; CD94/NKG2 molecules are the only Qa-1b receptors on NK cells.","method":"Cloning and expression, novel blocking anti-NKG2 mAb, binding assay, molecular analysis of cytoplasmic domains","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 — direct ligand-binding evidence with blocking antibody plus molecular characterization","pmids":["10601355"],"is_preprint":false},{"year":2000,"finding":"Engagement of CD94/NKG2C on NK cells activates the MAPK (ERK) pathway; MEK inhibitor PD098059 reduces CD94/NKG2C-dependent TNF-α production and cytotoxicity; transfer of CD94/NKG2C/DAP12 into RBL cells reconstitutes calcium mobilization, serotonin release, and MAPK phosphorylation upon receptor cross-linking.","method":"MEK inhibitor pharmacological blockade, MAPK phosphorylation assay, RBL cell transfection with CD94/NKG2C/DAP12, calcium mobilization, serotonin release assay","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in heterologous cell line plus pharmacological inhibition identifying downstream signaling pathway","pmids":["11069065"],"is_preprint":false},{"year":2004,"finding":"CD94/NKG2C and CD94/NKG2A bind the top of HLA-E (α1/α2 domain) through mostly shared but partly distinct sets of HLA-E residues; two HLA-E mutations (D69A and H155A) selectively abrogate binding to CD94/NKG2A but not CD94/NKG2C, revealing differential contact residues for the activating versus inhibitory receptor.","method":"Alanine-scanning mutagenesis of HLA-E, binding analysis with soluble CD94/NKG2A and CD94/NKG2C","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with recombinant proteins mapping binding interface","pmids":["14971033"],"is_preprint":false},{"year":2004,"finding":"The KLRC2 (NKG2C) gene is subject to complete homozygous deletion in ~4% of humans (deletion allele frequency ~20%), established by molecular genetic analysis identifying the deletion breakpoint 1.5–1.8 kb telomeric from the 3′ end of NKG2A.","method":"PCR genotyping, sequence comparison of intergenic regions in deletion versus wild-type haplotypes","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 1–2 — precise molecular mapping of deletion breakpoint with PCR-based genotyping","pmids":["14688071"],"is_preprint":false},{"year":2005,"finding":"CD94/NKG2C is expressed on a CD8+ T cell subset, is coupled to DAP12/KARAP (co-precipitated by anti-CD94 mAb), and its engagement triggers cytotoxicity, cytokine production, IL-2Rα upregulation, and proliferation in CD94/NKG2C+ T cell clones, establishing it as a functional alternative T cell activation pathway.","method":"Co-immunoprecipitation (anti-CD94 pulldown of DAP12), cytotoxicity assay, cytokine production assay, proliferation assay, flow cytometry","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 — co-IP plus multiple functional assays in primary T cell clones","pmids":["15940674"],"is_preprint":false},{"year":2009,"finding":"IL-12 transiently induces surface NKG2A expression on CD94/NKG2C+ NK cells (including upon co-culture with HCMV-infected dendritic cells, blocked by anti-IL-12 mAb), and this de novo NKG2A inhibits the cytolytic activity of NKG2C+ NK clones upon HLA-E engagement, revealing a negative regulatory feedback mechanism.","method":"In vitro stimulation with irradiated PBMC or rIL-12, anti-IL-12 mAb blockade, anti-NKG2A mAb functional inhibition assay, flow cytometry","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (cytokine blockade, mAb functional inhibition) establishing regulatory feedback","pmids":["19124726"],"is_preprint":false},{"year":2012,"finding":"NMR-based structural study of the DAP12-NKG2C transmembrane helix complex in explicit membranes revealed that five functionally required interfacial residues (two Asp and two Thr in DAP12 dimer, one Lys in NKG2C) form a stable network of salt bridges and hydrogen bonds; MD simulations refined side-chain arrangements consistent with available experimental constraints.","method":"NMR observable-based MD simulation in explicit micelles and bilayers, distance restraints","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 1 — computational refinement of NMR structure, single study with simulation, no independent mutagenesis validation reported here","pmids":["22500771"],"is_preprint":false},{"year":2013,"finding":"NKG2C zygosity (gene copy number) quantitatively influences CD94/NKG2C surface receptor levels, calcium influx signaling, degranulation, and IL-15-dependent proliferation upon receptor engagement, establishing a mechanistic link between KLRC2 copy number and receptor functional output in NK cells.","method":"Flow cytometry (surface levels, degranulation CD107a), intracellular calcium mobilization assay, proliferation assay, NKG2C genotyping in cohort","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple functional assays linking gene dose to receptor signaling, replicated across subjects","pmids":["24030638"],"is_preprint":false},{"year":2014,"finding":"Expansion of NKG2C+ NK cells in response to HCMV requires both IL-12 from CD14+ inflammatory monocytes and the CD94/NKG2C/HLA-E axis: IL-12 neutralization substantially reduced NKG2C+ subset expansion and CD25 upregulation, while NKG2C blockade or HLA-E silencing in infected fibroblasts greatly impaired expansion.","method":"Co-culture system with HCMV-infected fibroblasts and monocytes, IL-12 neutralizing antibody, NKG2C-blocking mAb, HLA-E siRNA silencing, flow cytometry","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal interventions (cytokine neutralization, receptor blocking, ligand silencing) in same experimental system","pmids":["25384219"],"is_preprint":false},{"year":2015,"finding":"HLA-E regulates NKG2C+ NK cell degranulation (CD107a) in a peptide-restricted manner: only 4 specific peptides (CMV-I, A80, B13, and HLA-G-derived) enhance NKG2C-mediated activation, and the HLA-E:G peptide complex triggers NKG2C receptor internalization reversible by bafilomycin.","method":"Degranulation assay (CD107a), flow cytometry, peptide-pulsed HLA-E target cells, bafilomycin treatment","journal":"Human immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay with pharmacological validation, single lab","pmids":["26382247"],"is_preprint":false},{"year":2016,"finding":"NKG2C-deficient (NKG2C−/−) humans still generate adaptive NK cells with characteristic footprints (terminally differentiated phenotype, epigenetic IFN-γ promoter remodeling, functional reprogramming); these adaptive NK cells express high CD2, which synergistically enhances ERK and S6RP phosphorylation after CD16 ligation and is critical for antibody-coated target cell responses.","method":"NK cell repertoire analysis in 60 NKG2C−/− donors, phospho-flow (ERK, S6RP), CD2 blocking/stimulation, ADCC assay, epigenetic methylation analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — natural human gene deletion model with multiple orthogonal functional methods and signaling assays","pmids":["27117418"],"is_preprint":false},{"year":2017,"finding":"Activation of CD94/NKG2C by ligands displayed on HCMV-infected cells is dependent on viral strain: clinical isolates and endotheliotropic TB40/E strain (but not laboratory strains AD169/Towne) activate Jurkat-NKG2C+ reporter cells, and HLA-E+ 721.221 cells trigger NKG2C/DAP12-dependent NFAT/AP1 reporter activity antagonized by anti-NKG2C and anti-HLA-E mAbs.","method":"Jurkat reporter cell line expressing CD94/NKG2C/DAP12 with NFAT/AP1-luciferase reporter, antibody blocking, co-culture with HCMV-infected cells","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 1–2 — reconstituted reporter system with antibody blocking; single lab, viral strain dependency not fully resolved","pmids":["29114247"],"is_preprint":false},{"year":2019,"finding":"NKG2C+ adaptive NK cells constitutively express HLA-DR and, after HCMV antigen loading via CD16 (accompanied by CD16 loss and CX3CR1 decrease), present HCMV antigens in an HLA-DR-dependent manner to CD28-negative effector-memory CD4+ T cells, inducing degranulation (CD107a) and Th1 cytokines (IFN-γ, TNF-α).","method":"Flow cytometry, HLA-DR blocking antibody, co-culture of HCMV-antigen-loaded NK cells with autologous CD4+ T cells, intracellular cytokine staining","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional antigen presentation assay with HLA-DR blocking, single lab","pmids":["31001281"],"is_preprint":false},{"year":1995,"finding":"NKG2C is expressed as a 36-kDa glycoprotein on NK cells; a soluble recombinant NKG2C protein binds specifically to K562 and RPMI 8866 cells (NK targets/feeders) but not to other hematopoietic lines, and binding structures disappear concomitant with loss of K562 susceptibility to killing upon differentiation induction.","method":"In vitro translation, recombinant protein expression, immunoprecipitation, soluble receptor binding assay, target cell differentiation","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 1–2 — recombinant protein binding assay identifying target cell ligand, single lab","pmids":["7589093"],"is_preprint":false},{"year":2010,"finding":"In γδ T cells, CD94/NKG2C associated with KARAP/DAP12 is fully functional (mediates IFN-γ production, proliferation, and cytolytic activity); when NKG2A and NKG2C are co-expressed on the same cell, the inhibitory signal from NKG2A prevails over NKG2C-mediated activation.","method":"IFN-γ ELISA, proliferation assay, cytolytic activity assay, functional co-expression experiments with NKG2A/NKG2C double-positive cells","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional readouts in primary γδ T cells, single lab","pmids":["20952657"],"is_preprint":false},{"year":2022,"finding":"A distinct CD56hiCD161-CD8+ T-cell population in human liver sinusoids highly expresses NKG2C and exerts NKG2C-mediated NK-like effector functions (cytotoxicity, cytokine production) in the absence of TCR stimulation, activated by innate cytokines (IL-12/18, IL-15).","method":"CITE-seq with TCR-seq, flow cytometry, functional assays (TCR-independent NKG2C ligation), intrahepatic cell isolation","journal":"Journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2 — TCR-independent functional assay with NKG2C ligation, multi-omic characterization, single lab","pmids":["35644434"],"is_preprint":false}],"current_model":"KLRC2 (NKG2C) encodes a C-type lectin-like type II transmembrane protein that heterodimerizes covalently with CD94 and non-covalently associates with the ITAM-bearing adaptor DAP12 via complementary charged transmembrane residues; the CD94/NKG2C complex binds HLA-E in a peptide-dependent manner with lower affinity than the inhibitory CD94/NKG2A, engages a mostly overlapping but partly distinct set of HLA-E residues, and upon ligation signals through DAP12-dependent MAPK/ERK activation and calcium mobilization to trigger NK (and T) cell cytotoxicity, cytokine production, and proliferation; KLRC2 copy number quantitatively modulates receptor surface density and downstream signaling strength, and HCMV-driven expansion of NKG2C+ adaptive NK cells requires both IL-12 from monocytes and the NKG2C/HLA-E axis, with CD2 providing co-stimulatory signal 2 when NKG2C is absent."},"narrative":{"teleology":[{"year":1995,"claim":"Initial identification of NKG2C as an NK cell surface glycoprotein whose soluble form binds NK target cells established it as a candidate recognition receptor, though its ligand and signaling mode were unknown.","evidence":"Recombinant soluble NKG2C binding assay on K562/RPMI 8866 target cells with differentiation controls","pmids":["7589093"],"confidence":"Medium","gaps":["Ligand identity on target cells not determined","Activating versus inhibitory function not resolved","Single-lab observation without independent replication"]},{"year":1997,"claim":"Chimeric receptor experiments resolved the key question of whether NKG2C delivers activating or inhibitory signals, demonstrating that NKG2C triggers cytotoxicity and calcium mobilization without recruiting the inhibitory phosphatase SHP-1.","evidence":"NKG2C/NKR-P1C chimeric receptors in RNK-16 cells; cytolytic assays, calcium flux, SHP-1 co-IP","pmids":["9103421"],"confidence":"High","gaps":["Signaling adaptor mediating activation not yet identified","Physiological ligand still unknown"]},{"year":1998,"claim":"Two contemporaneous studies established the molecular architecture of the activating receptor complex: NKG2C covalently heterodimerizes with CD94 and non-covalently recruits the ITAM-bearing adaptor DAP12 via charge-complementary transmembrane residues, explaining how a receptor lacking intrinsic signaling motifs triggers activation.","evidence":"Co-IP, transmembrane mutagenesis, COS7 co-transfection, redirected killing assays","pmids":["9655483","9485212"],"confidence":"High","gaps":["Stoichiometry and structural details of the DAP12–NKG2C transmembrane assembly not resolved","Downstream signaling cascade not mapped"]},{"year":1999,"claim":"Identification of HLA-E as the ligand for CD94/NKG2C—and demonstration that NKG2C binds HLA-E with lower affinity and faster kinetics than inhibitory NKG2A—answered how activation and inhibition are balanced through a shared ligand with differential binding strength.","evidence":"Surface plasmon resonance with recombinant soluble CD94/NKG2C and peptide-loaded HLA-E; mouse Qa-1b binding with blocking mAb","pmids":["10428963","10601355"],"confidence":"High","gaps":["Structural basis for affinity difference between NKG2C and NKG2A not determined","Peptide selectivity of NKG2C recognition not fully characterized"]},{"year":2000,"claim":"Reconstitution of the complete CD94/NKG2C/DAP12 complex in heterologous cells mapped the downstream signaling cascade to MAPK/ERK, showing that MEK inhibition blocks TNF-α production and cytotoxicity—establishing the first defined intracellular pathway downstream of NKG2C engagement.","evidence":"RBL cell transfection with CD94/NKG2C/DAP12; MAPK phosphorylation, calcium flux, serotonin release; MEK inhibitor PD098059","pmids":["11069065"],"confidence":"High","gaps":["Role of other signaling branches (PI3K, NF-κB) not addressed","In vivo signaling relevance not tested"]},{"year":2004,"claim":"Alanine-scanning mutagenesis of HLA-E resolved how CD94/NKG2C and CD94/NKG2A discriminate the same ligand: they share most contact residues on the HLA-E α1/α2 platform, but two residues (D69, H155) are selectively required for NKG2A but not NKG2C binding, providing a structural explanation for differential affinity.","evidence":"Systematic alanine mutagenesis of HLA-E surface residues; binding analysis with soluble CD94/NKG2A and CD94/NKG2C","pmids":["14971033"],"confidence":"High","gaps":["No crystal structure of CD94/NKG2C–HLA-E complex available","Energetic contribution of each contact not quantified"]},{"year":2004,"claim":"Discovery that KLRC2 undergoes complete homozygous deletion in ~4% of humans (allele frequency ~20%) revealed that the gene is dispensable for survival and created a natural human knockout model for studying NKG2C function.","evidence":"PCR genotyping and breakpoint mapping in deletion versus wild-type haplotypes","pmids":["14688071"],"confidence":"High","gaps":["Functional consequences of deletion for immune defense not yet assessed","Selective pressure maintaining or driving deletion frequency unknown"]},{"year":2005,"claim":"Extension of NKG2C function beyond NK cells: demonstration that CD94/NKG2C coupled to DAP12 on CD8+ T cells triggers cytotoxicity, cytokine release, and proliferation established NKG2C as an alternative activation pathway for adaptive lymphocytes.","evidence":"Co-IP of DAP12 via anti-CD94 in T cell clones; cytotoxicity, cytokine, and proliferation assays","pmids":["15940674"],"confidence":"High","gaps":["Proportion and phenotype of NKG2C+ T cells in different tissues not systematically characterized","TCR-independent versus TCR-dependent triggering not dissected"]},{"year":2009,"claim":"Discovery of a negative feedback loop: IL-12 transiently induces inhibitory NKG2A on NKG2C+ NK cells, dampening their HLA-E-mediated activation—establishing that NKG2A/NKG2C balance is dynamically regulated by cytokine milieu.","evidence":"IL-12 stimulation and anti-IL-12 blockade in co-culture with HCMV-infected DCs; anti-NKG2A functional inhibition","pmids":["19124726"],"confidence":"High","gaps":["Transcriptional mechanism of IL-12-driven NKG2A induction on NKG2C+ cells not identified","Duration and reversibility of NKG2A co-expression in vivo unknown"]},{"year":2012,"claim":"NMR-restrained MD simulations revealed the atomic-level arrangement of the DAP12–NKG2C transmembrane assembly: a salt-bridge/hydrogen-bond network involving two Asp and two Thr in the DAP12 dimer and one Lys in NKG2C stabilizes the complex within the membrane.","evidence":"NMR observable-based MD simulation in explicit micelles and lipid bilayers","pmids":["22500771"],"confidence":"Medium","gaps":["No independent mutagenesis validation of predicted contacts reported in this study","Structure of the full ectodomain–transmembrane complex not resolved","Computational model in micelles may not fully reflect native bilayer environment"]},{"year":2013,"claim":"Gene dosage quantitatively controls NKG2C function: KLRC2 copy number determines receptor surface density, calcium signaling amplitude, degranulation efficiency, and IL-15-dependent proliferation, providing a mechanistic basis for population-level variation in NKG2C-dependent immune responses.","evidence":"Flow cytometry, calcium mobilization, CD107a degranulation, and proliferation assays stratified by NKG2C genotype across multiple donors","pmids":["24030638"],"confidence":"High","gaps":["Whether gene dose effects extend to in vivo viral control not tested","Epigenetic regulation of KLRC2 expression beyond copy number not explored"]},{"year":2014,"claim":"HCMV-driven expansion of adaptive NKG2C+ NK cells was shown to require dual signals: monocyte-derived IL-12 and direct NKG2C/HLA-E engagement, with each independently necessary—resolving a long-standing question about the signals driving adaptive NK cell generation.","evidence":"Co-culture with HCMV-infected fibroblasts and monocytes; IL-12 neutralization, NKG2C blocking mAb, HLA-E siRNA silencing","pmids":["25384219"],"confidence":"High","gaps":["Role of other cytokines (IL-18, IL-15) as co-factors not fully dissected in this system","Molecular mechanism linking HLA-E engagement to clonal expansion not identified"]},{"year":2016,"claim":"Analysis of NKG2C-null humans revealed functional redundancy in adaptive NK cell differentiation: NKG2C−/− individuals generate adaptive NK cells with characteristic epigenetic and phenotypic features, using CD2 as an alternative co-stimulatory receptor that synergistically enhances ERK/S6RP signaling after CD16 ligation.","evidence":"Repertoire analysis in 60 NKG2C−/− donors; phospho-flow for ERK/S6RP; CD2 blocking; ADCC assay; IFN-γ promoter methylation analysis","pmids":["27117418"],"confidence":"High","gaps":["Whether CD2-dependent adaptive NK cells are functionally equivalent to NKG2C+ cells in viral control unknown","Epigenetic mechanisms driving compensatory pathway engagement not defined"]},{"year":2017,"claim":"Viral strain specificity of NKG2C activation was established: clinical HCMV isolates and endotheliotropic TB40/E, but not laboratory strains AD169/Towne, activate CD94/NKG2C/DAP12-dependent NFAT/AP1 reporter signaling, suggesting that specific viral gene products or altered HLA-E peptide repertoires determine receptor engagement.","evidence":"Jurkat reporter cells expressing CD94/NKG2C/DAP12 with NFAT/AP1-luciferase; antibody blocking; co-culture with HCMV-infected cells","pmids":["29114247"],"confidence":"Medium","gaps":["Specific viral gene or peptide responsible for strain-dependent activation not identified","Reporter cell system may not fully recapitulate primary NK cell signaling thresholds"]},{"year":2019,"claim":"NKG2C+ adaptive NK cells were shown to constitutively express HLA-DR and function as unconventional antigen-presenting cells, loading HCMV antigens via CD16 and presenting them to effector-memory CD4+ T cells—revealing an unanticipated bridge between innate and adaptive immunity.","evidence":"HLA-DR blocking antibody; co-culture of HCMV-antigen-loaded NK cells with autologous CD4+ T cells; intracellular cytokine staining","pmids":["31001281"],"confidence":"Medium","gaps":["Mechanism of antigen processing and HLA-DR loading in NK cells not characterized","In vivo relevance of NK cell antigen presentation not established","Single-lab finding without independent replication"]},{"year":2022,"claim":"Identification of a liver-resident CD56hiCD161−CD8+ T cell population highly expressing NKG2C demonstrated tissue-specific innate-like T cell function driven by NKG2C ligation independently of TCR, expanding the functional scope of NKG2C to hepatic immunity.","evidence":"CITE-seq with TCR-seq, flow cytometry, TCR-independent NKG2C functional assays on intrahepatic cells","pmids":["35644434"],"confidence":"Medium","gaps":["Ligand (HLA-E or other) driving NKG2C activation in liver sinusoidal environment not confirmed","Contribution of this subset to liver disease or viral hepatitis defense unknown","Single-cohort observation"]},{"year":null,"claim":"Key unresolved questions include the crystal structure of the CD94/NKG2C–HLA-E ternary complex, the specific HCMV-derived peptides or viral factors responsible for strain-dependent NKG2C activation, the transcriptional and epigenetic regulation of KLRC2 during adaptive NK cell differentiation, and the in vivo contribution of NKG2C signaling to HCMV control versus the compensatory CD2-dependent pathway.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of CD94/NKG2C–HLA-E complex","Viral determinants of strain-specific NKG2C activation unidentified","In vivo functional equivalence of NKG2C-dependent versus CD2-dependent adaptive NK pathways untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,5,11]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,11,17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,5,8,12,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,11,15]}],"complexes":["CD94/NKG2C","CD94/NKG2C/DAP12"],"partners":["CD94","DAP12","HLA-E","CD2"],"other_free_text":[]},"mechanistic_narrative":"KLRC2 (NKG2C) encodes an activating C-type lectin-like receptor that heterodimerizes covalently with CD94 and associates non-covalently with the ITAM-bearing adaptor DAP12 through complementary charged transmembrane residues (Lys in NKG2C, Asp/Thr in DAP12), forming a trimolecular signaling complex on NK cells, γδ T cells, and subsets of CD8+ T cells [PMID:9655483, PMID:22500771, PMID:20952657]. The CD94/NKG2C complex recognizes HLA-E in a peptide-dependent manner with lower affinity and faster kinetics than the inhibitory CD94/NKG2A, engaging a largely overlapping but partly distinct set of HLA-E contact residues; upon ligation it signals through DAP12-dependent MAPK/ERK activation and calcium mobilization to trigger cytotoxicity, cytokine production (TNF-α, IFN-γ), and proliferation [PMID:10428963, PMID:14971033, PMID:11069065, PMID:9103421]. KLRC2 gene copy number quantitatively controls receptor surface density, calcium signaling magnitude, and degranulation capacity, and HCMV-driven expansion of NKG2C+ adaptive NK cells requires both monocyte-derived IL-12 and the NKG2C/HLA-E axis, with CD2 serving as an alternative co-stimulatory pathway when NKG2C is absent [PMID:24030638, PMID:25384219, PMID:27117418]. The KLRC2 locus undergoes homozygous deletion in approximately 4% of humans, yet NKG2C-deficient individuals can still generate adaptive NK cells with epigenetically reprogrammed IFN-γ loci, indicating functional redundancy in the adaptive NK cell differentiation program [PMID:14688071, PMID:27117418]."},"prefetch_data":{"uniprot":{"accession":"P26717","full_name":"NKG2-C type II integral membrane protein","aliases":["CD159 antigen-like family member C","NK cell receptor C","NKG2-C-activating NK receptor"],"length_aa":231,"mass_kda":26.2,"function":"Immune activating receptor involved in self-nonself discrimination. In complex with KLRD1 on cytotoxic lymphocyte subsets, recognizes non-classical major histocompatibility (MHC) class Ib HLA-E loaded with signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules, likely playing a role in the generation and effector functions of adaptive natural killer (NK) cells and in maternal-fetal tolerance during pregnancy (PubMed:30134159, PubMed:37264229, PubMed:9754572). Regulates the effector functions of terminally differentiated cytotoxic lymphocyte subsets, and in particular may play a role in adaptive NK cell response to viral infection (PubMed:20952657, PubMed:21825173). Upon HLA-E-peptide binding, transmits intracellular signals via the adapter protein TYROBP/DAP12, triggering the phosphorylation of proximal signaling molecules and cell activation (PubMed:15940674, PubMed:9655483)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P26717/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KLRC2","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1165,"dependency_fraction":0.002575107296137339},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KLRC2","total_profiled":1310},"omim":[{"mim_id":"606782","title":"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A","url":"https://www.omim.org/entry/606782"},{"mim_id":"602894","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1","url":"https://www.omim.org/entry/602894"},{"mim_id":"602891","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 2; KLRC2","url":"https://www.omim.org/entry/602891"},{"mim_id":"161555","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1","url":"https://www.omim.org/entry/161555"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":9.0},{"tissue":"lymphoid tissue","ntpm":5.1}],"url":"https://www.proteinatlas.org/search/KLRC2"},"hgnc":{"alias_symbol":["NKG2-C","CD159c","NKG2C"],"prev_symbol":[]},"alphafold":{"accession":"P26717","domains":[{"cath_id":"3.10.100.10","chopping":"122-231","consensus_level":"medium","plddt":94.7558,"start":122,"end":231}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26717","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26717-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26717-F1-predicted_aligned_error_v6.png","plddt_mean":73.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KLRC2","jax_strain_url":"https://www.jax.org/strain/search?query=KLRC2"},"sequence":{"accession":"P26717","fasta_url":"https://rest.uniprot.org/uniprotkb/P26717.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26717/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26717"}},"corpus_meta":[{"pmid":"22180440","id":"PMC_22180440","title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22180440","citation_count":526,"is_preprint":false},{"pmid":"9655483","id":"PMC_9655483","title":"Association of DAP12 with activating CD94/NKG2C NK cell receptors.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9655483","citation_count":429,"is_preprint":false},{"pmid":"16384928","id":"PMC_16384928","title":"Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16384928","citation_count":355,"is_preprint":false},{"pmid":"23077239","id":"PMC_23077239","title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23077239","citation_count":306,"is_preprint":false},{"pmid":"10428963","id":"PMC_10428963","title":"Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10428963","citation_count":298,"is_preprint":false},{"pmid":"22105371","id":"PMC_22105371","title":"CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22105371","citation_count":240,"is_preprint":false},{"pmid":"16741880","id":"PMC_16741880","title":"Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.","date":"2006","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/16741880","citation_count":204,"is_preprint":false},{"pmid":"27117418","id":"PMC_27117418","title":"Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27117418","citation_count":190,"is_preprint":false},{"pmid":"9103421","id":"PMC_9103421","title":"Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9103421","citation_count":186,"is_preprint":false},{"pmid":"26416461","id":"PMC_26416461","title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.","date":"2015","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/26416461","citation_count":185,"is_preprint":false},{"pmid":"10601355","id":"PMC_10601355","title":"Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10601355","citation_count":166,"is_preprint":false},{"pmid":"25384219","id":"PMC_25384219","title":"IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25384219","citation_count":158,"is_preprint":false},{"pmid":"24740502","id":"PMC_24740502","title":"Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24740502","citation_count":149,"is_preprint":false},{"pmid":"24442432","id":"PMC_24442432","title":"Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24442432","citation_count":144,"is_preprint":false},{"pmid":"19910789","id":"PMC_19910789","title":"Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.","date":"2010","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19910789","citation_count":122,"is_preprint":false},{"pmid":"37963457","id":"PMC_37963457","title":"Single-cell atlas of healthy human blood unveils age-related loss of NKG2C+GZMB-CD8+ memory T cells and accumulation of type 2 memory T cells.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/37963457","citation_count":121,"is_preprint":false},{"pmid":"33500568","id":"PMC_33500568","title":"Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19.","date":"2021","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33500568","citation_count":104,"is_preprint":false},{"pmid":"24666761","id":"PMC_24666761","title":"The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.","date":"2014","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24666761","citation_count":93,"is_preprint":false},{"pmid":"9485212","id":"PMC_9485212","title":"The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9485212","citation_count":93,"is_preprint":false},{"pmid":"25150297","id":"PMC_25150297","title":"Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25150297","citation_count":86,"is_preprint":false},{"pmid":"9683661","id":"PMC_9683661","title":"The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex.","date":"1998","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9683661","citation_count":84,"is_preprint":false},{"pmid":"22965785","id":"PMC_22965785","title":"Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.","date":"2012","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22965785","citation_count":81,"is_preprint":false},{"pmid":"14971033","id":"PMC_14971033","title":"The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14971033","citation_count":79,"is_preprint":false},{"pmid":"24030638","id":"PMC_24030638","title":"NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24030638","citation_count":74,"is_preprint":false},{"pmid":"15940674","id":"PMC_15940674","title":"The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15940674","citation_count":73,"is_preprint":false},{"pmid":"23396942","id":"PMC_23396942","title":"Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23396942","citation_count":73,"is_preprint":false},{"pmid":"12480700","id":"PMC_12480700","title":"Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12480700","citation_count":73,"is_preprint":false},{"pmid":"14688071","id":"PMC_14688071","title":"Molecular genetic analyses of human NKG2C (KLRC2) gene deletion.","date":"2004","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14688071","citation_count":66,"is_preprint":false},{"pmid":"26994220","id":"PMC_26994220","title":"Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26994220","citation_count":63,"is_preprint":false},{"pmid":"19124726","id":"PMC_19124726","title":"IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19124726","citation_count":63,"is_preprint":false},{"pmid":"22074011","id":"PMC_22074011","title":"NKG2C deletion is a risk factor of HIV infection.","date":"2012","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/22074011","citation_count":61,"is_preprint":false},{"pmid":"17709553","id":"PMC_17709553","title":"Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17709553","citation_count":58,"is_preprint":false},{"pmid":"18097224","id":"PMC_18097224","title":"NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.","date":"2008","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18097224","citation_count":56,"is_preprint":false},{"pmid":"27913630","id":"PMC_27913630","title":"Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27913630","citation_count":55,"is_preprint":false},{"pmid":"28031335","id":"PMC_28031335","title":"NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28031335","citation_count":55,"is_preprint":false},{"pmid":"16488482","id":"PMC_16488482","title":"Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.","date":"2006","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16488482","citation_count":54,"is_preprint":false},{"pmid":"15517612","id":"PMC_15517612","title":"Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15517612","citation_count":54,"is_preprint":false},{"pmid":"26382247","id":"PMC_26382247","title":"HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.","date":"2015","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26382247","citation_count":53,"is_preprint":false},{"pmid":"26617607","id":"PMC_26617607","title":"Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?","date":"2015","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26617607","citation_count":52,"is_preprint":false},{"pmid":"20132973","id":"PMC_20132973","title":"CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.","date":"2010","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20132973","citation_count":51,"is_preprint":false},{"pmid":"28791125","id":"PMC_28791125","title":"NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147.","date":"2017","source":"Clinical & translational immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28791125","citation_count":51,"is_preprint":false},{"pmid":"23918974","id":"PMC_23918974","title":"Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23918974","citation_count":50,"is_preprint":false},{"pmid":"28979268","id":"PMC_28979268","title":"NKG2C+NKG2A- Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV Infection.","date":"2017","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28979268","citation_count":48,"is_preprint":false},{"pmid":"36319065","id":"PMC_36319065","title":"Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.","date":"2022","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36319065","citation_count":46,"is_preprint":false},{"pmid":"12618865","id":"PMC_12618865","title":"Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population.","date":"2003","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12618865","citation_count":46,"is_preprint":false},{"pmid":"31001281","id":"PMC_31001281","title":"Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31001281","citation_count":43,"is_preprint":false},{"pmid":"23255011","id":"PMC_23255011","title":"Spotlight on NKG2C and the human NK-cell response to CMV infection.","date":"2012","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23255011","citation_count":42,"is_preprint":false},{"pmid":"26940026","id":"PMC_26940026","title":"Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.","date":"2016","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26940026","citation_count":41,"is_preprint":false},{"pmid":"22708664","id":"PMC_22708664","title":"Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction.","date":"2012","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/22708664","citation_count":41,"is_preprint":false},{"pmid":"34174441","id":"PMC_34174441","title":"Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.","date":"2021","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34174441","citation_count":39,"is_preprint":false},{"pmid":"27314055","id":"PMC_27314055","title":"NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.","date":"2016","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/27314055","citation_count":39,"is_preprint":false},{"pmid":"29731749","id":"PMC_29731749","title":"Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral Infections.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29731749","citation_count":39,"is_preprint":false},{"pmid":"29851983","id":"PMC_29851983","title":"Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques.","date":"2018","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/29851983","citation_count":38,"is_preprint":false},{"pmid":"30211828","id":"PMC_30211828","title":"NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.","date":"2019","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/30211828","citation_count":36,"is_preprint":false},{"pmid":"15843571","id":"PMC_15843571","title":"Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15843571","citation_count":36,"is_preprint":false},{"pmid":"20952657","id":"PMC_20952657","title":"NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.","date":"2010","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/20952657","citation_count":35,"is_preprint":false},{"pmid":"23968979","id":"PMC_23968979","title":"Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.","date":"2013","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23968979","citation_count":35,"is_preprint":false},{"pmid":"27801784","id":"PMC_27801784","title":"The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27801784","citation_count":31,"is_preprint":false},{"pmid":"24079744","id":"PMC_24079744","title":"Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility.","date":"2013","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/24079744","citation_count":30,"is_preprint":false},{"pmid":"16906533","id":"PMC_16906533","title":"Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16906533","citation_count":30,"is_preprint":false},{"pmid":"35644434","id":"PMC_35644434","title":"Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner.","date":"2022","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35644434","citation_count":29,"is_preprint":false},{"pmid":"7589093","id":"PMC_7589093","title":"NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7589093","citation_count":28,"is_preprint":false},{"pmid":"29220498","id":"PMC_29220498","title":"NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation.","date":"2018","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29220498","citation_count":28,"is_preprint":false},{"pmid":"36899273","id":"PMC_36899273","title":"Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications.","date":"2023","source":"Archivum immunologiae et therapiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/36899273","citation_count":25,"is_preprint":false},{"pmid":"17767552","id":"PMC_17767552","title":"Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.","date":"2007","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/17767552","citation_count":25,"is_preprint":false},{"pmid":"22500771","id":"PMC_22500771","title":"NMR observable-based structure refinement of DAP12-NKG2C activating immunoreceptor complex in explicit membranes.","date":"2012","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22500771","citation_count":24,"is_preprint":false},{"pmid":"18700876","id":"PMC_18700876","title":"Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.","date":"2008","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/18700876","citation_count":24,"is_preprint":false},{"pmid":"17035308","id":"PMC_17035308","title":"NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17035308","citation_count":24,"is_preprint":false},{"pmid":"32517137","id":"PMC_32517137","title":"Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/32517137","citation_count":23,"is_preprint":false},{"pmid":"31612635","id":"PMC_31612635","title":"Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients.","date":"2019","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/31612635","citation_count":23,"is_preprint":false},{"pmid":"25814467","id":"PMC_25814467","title":"Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.","date":"2015","source":"Antiviral therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25814467","citation_count":23,"is_preprint":false},{"pmid":"22170546","id":"PMC_22170546","title":"Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.","date":"2012","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/22170546","citation_count":22,"is_preprint":false},{"pmid":"35628668","id":"PMC_35628668","title":"NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35628668","citation_count":22,"is_preprint":false},{"pmid":"26312867","id":"PMC_26312867","title":"Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population.","date":"2015","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26312867","citation_count":21,"is_preprint":false},{"pmid":"24307732","id":"PMC_24307732","title":"Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24307732","citation_count":21,"is_preprint":false},{"pmid":"31867015","id":"PMC_31867015","title":"Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31867015","citation_count":21,"is_preprint":false},{"pmid":"29114247","id":"PMC_29114247","title":"Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System.","date":"2017","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29114247","citation_count":21,"is_preprint":false},{"pmid":"39288262","id":"PMC_39288262","title":"NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control.","date":"2024","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/39288262","citation_count":20,"is_preprint":false},{"pmid":"26500647","id":"PMC_26500647","title":"Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients.","date":"2015","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26500647","citation_count":20,"is_preprint":false},{"pmid":"32930385","id":"PMC_32930385","title":"CD56dim CD57- NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+ NKG2C+ memory-like NK cells.","date":"2020","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/32930385","citation_count":20,"is_preprint":false},{"pmid":"27179621","id":"PMC_27179621","title":"Human Adaptive Natural Killer Cells: Beyond NKG2C.","date":"2016","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27179621","citation_count":20,"is_preprint":false},{"pmid":"19694640","id":"PMC_19694640","title":"Women with pre-eclampsia have an altered NKG2A and NKG2C receptor expression on peripheral blood natural killer cells.","date":"2009","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/19694640","citation_count":20,"is_preprint":false},{"pmid":"27116381","id":"PMC_27116381","title":"Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.","date":"2016","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27116381","citation_count":19,"is_preprint":false},{"pmid":"25230289","id":"PMC_25230289","title":"Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.","date":"2014","source":"Journal of acquired immune deficiency syndromes (1999)","url":"https://pubmed.ncbi.nlm.nih.gov/25230289","citation_count":19,"is_preprint":false},{"pmid":"33493558","id":"PMC_33493558","title":"HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors.","date":"2021","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33493558","citation_count":18,"is_preprint":false},{"pmid":"35401541","id":"PMC_35401541","title":"Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35401541","citation_count":18,"is_preprint":false},{"pmid":"25510434","id":"PMC_25510434","title":"Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus.","date":"2015","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25510434","citation_count":16,"is_preprint":false},{"pmid":"34990406","id":"PMC_34990406","title":"Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation.","date":"2022","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34990406","citation_count":16,"is_preprint":false},{"pmid":"27312142","id":"PMC_27312142","title":"Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data.","date":"2016","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27312142","citation_count":16,"is_preprint":false},{"pmid":"22920222","id":"PMC_22920222","title":"Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load.","date":"2012","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/22920222","citation_count":16,"is_preprint":false},{"pmid":"30405633","id":"PMC_30405633","title":"Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30405633","citation_count":16,"is_preprint":false},{"pmid":"24305414","id":"PMC_24305414","title":"NKG2C gene deletion in the Mexican population and lack of association to respiratory viral infections.","date":"2013","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24305414","citation_count":15,"is_preprint":false},{"pmid":"19811091","id":"PMC_19811091","title":"The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus.","date":"2009","source":"Viral immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19811091","citation_count":15,"is_preprint":false},{"pmid":"24279916","id":"PMC_24279916","title":"NKG2C, HLA-E and their association with psoriasis.","date":"2013","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/24279916","citation_count":14,"is_preprint":false},{"pmid":"32131843","id":"PMC_32131843","title":"Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.","date":"2020","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/32131843","citation_count":13,"is_preprint":false},{"pmid":"11069065","id":"PMC_11069065","title":"Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11069065","citation_count":13,"is_preprint":false},{"pmid":"37426645","id":"PMC_37426645","title":"Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37426645","citation_count":12,"is_preprint":false},{"pmid":"30461721","id":"PMC_30461721","title":"Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.","date":"2019","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/30461721","citation_count":12,"is_preprint":false},{"pmid":"9212363","id":"PMC_9212363","title":"The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules.","date":"1997","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/9212363","citation_count":12,"is_preprint":false},{"pmid":"30018803","id":"PMC_30018803","title":"Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis.","date":"2018","source":"RMD open","url":"https://pubmed.ncbi.nlm.nih.gov/30018803","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51663,"output_tokens":5012,"usd":0.115085},"stage2":{"model":"claude-opus-4-6","input_tokens":8580,"output_tokens":4206,"usd":0.222075},"total_usd":0.33716,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"NKG2C delivers an activating signal in NK cells: chimeric receptor constructs (NKG2C/NKR-P1C) stimulated lytic activity and calcium mobilization in RNK-16 cells, while SHP-1 did not associate with the NKG2C cytoplasmic domain (unlike the inhibitory NKG2A), establishing NKG2C as an activating receptor.\",\n      \"method\": \"Chimeric receptor transfection in rat NK cell line, cytolytic assay, calcium mobilization, immunoprecipitation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with chimeric receptors, functional assays, and co-immunoprecipitation in single rigorous study\",\n      \"pmids\": [\"9103421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD94/NKG2C forms a non-covalent complex with DAP12 (an ITAM-bearing adaptor), and charged residues in the transmembrane domains of both DAP12 and NKG2C are required for this interaction and for efficient surface expression of the receptor.\",\n      \"method\": \"Co-immunoprecipitation, surface expression analysis, transmembrane domain mutagenesis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis and co-IP identifying the molecular basis of receptor assembly\",\n      \"pmids\": [\"9655483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"NKG2C (Kp39) covalently associates with CD94 to form an activating receptor complex on a subset of NKG2A-negative NK cells; cytolytic activity of NKG2A−P25+ NK clones can be triggered by an NKG2C-specific mAb in redirected killing, and biochemical analysis of COS7 cells co-transfected with CD94 and NKG2C confirmed the identity of Kp39 as NKG2C.\",\n      \"method\": \"Immunoprecipitation, peptide mapping, RT-PCR, COS7 co-transfection, redirected killing assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution plus functional killing assay, multiple orthogonal methods\",\n      \"pmids\": [\"9485212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD94/NKG2C binds HLA-E in a peptide-dependent manner; the activating CD94/NKG2C receptor has a lower binding affinity for HLA-E than the inhibitory CD94/NKG2A receptor, with very fast association and dissociation kinetics, and the affinity of peptide-HLA-E complexes correlates with NK cell response.\",\n      \"method\": \"Surface plasmon resonance (kinetic binding analysis) with soluble recombinant HLA-E and soluble CD94/NKG2C proteins, peptide-dependent assembly\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assay with recombinant proteins, quantitative kinetics, peptide dependency established\",\n      \"pmids\": [\"10428963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Mouse CD94/NKG2C (and CD94/NKG2E) bind to the non-classical MHC class Ib molecule Qa-1b, the mouse functional counterpart of HLA-E, and these receptors likely function as activating receptors based on cytoplasmic domain features distinct from inhibitory NKG2A; CD94/NKG2 molecules are the only Qa-1b receptors on NK cells.\",\n      \"method\": \"Cloning and expression, novel blocking anti-NKG2 mAb, binding assay, molecular analysis of cytoplasmic domains\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct ligand-binding evidence with blocking antibody plus molecular characterization\",\n      \"pmids\": [\"10601355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Engagement of CD94/NKG2C on NK cells activates the MAPK (ERK) pathway; MEK inhibitor PD098059 reduces CD94/NKG2C-dependent TNF-α production and cytotoxicity; transfer of CD94/NKG2C/DAP12 into RBL cells reconstitutes calcium mobilization, serotonin release, and MAPK phosphorylation upon receptor cross-linking.\",\n      \"method\": \"MEK inhibitor pharmacological blockade, MAPK phosphorylation assay, RBL cell transfection with CD94/NKG2C/DAP12, calcium mobilization, serotonin release assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in heterologous cell line plus pharmacological inhibition identifying downstream signaling pathway\",\n      \"pmids\": [\"11069065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CD94/NKG2C and CD94/NKG2A bind the top of HLA-E (α1/α2 domain) through mostly shared but partly distinct sets of HLA-E residues; two HLA-E mutations (D69A and H155A) selectively abrogate binding to CD94/NKG2A but not CD94/NKG2C, revealing differential contact residues for the activating versus inhibitory receptor.\",\n      \"method\": \"Alanine-scanning mutagenesis of HLA-E, binding analysis with soluble CD94/NKG2A and CD94/NKG2C\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with recombinant proteins mapping binding interface\",\n      \"pmids\": [\"14971033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The KLRC2 (NKG2C) gene is subject to complete homozygous deletion in ~4% of humans (deletion allele frequency ~20%), established by molecular genetic analysis identifying the deletion breakpoint 1.5–1.8 kb telomeric from the 3′ end of NKG2A.\",\n      \"method\": \"PCR genotyping, sequence comparison of intergenic regions in deletion versus wild-type haplotypes\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — precise molecular mapping of deletion breakpoint with PCR-based genotyping\",\n      \"pmids\": [\"14688071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD94/NKG2C is expressed on a CD8+ T cell subset, is coupled to DAP12/KARAP (co-precipitated by anti-CD94 mAb), and its engagement triggers cytotoxicity, cytokine production, IL-2Rα upregulation, and proliferation in CD94/NKG2C+ T cell clones, establishing it as a functional alternative T cell activation pathway.\",\n      \"method\": \"Co-immunoprecipitation (anti-CD94 pulldown of DAP12), cytotoxicity assay, cytokine production assay, proliferation assay, flow cytometry\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — co-IP plus multiple functional assays in primary T cell clones\",\n      \"pmids\": [\"15940674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IL-12 transiently induces surface NKG2A expression on CD94/NKG2C+ NK cells (including upon co-culture with HCMV-infected dendritic cells, blocked by anti-IL-12 mAb), and this de novo NKG2A inhibits the cytolytic activity of NKG2C+ NK clones upon HLA-E engagement, revealing a negative regulatory feedback mechanism.\",\n      \"method\": \"In vitro stimulation with irradiated PBMC or rIL-12, anti-IL-12 mAb blockade, anti-NKG2A mAb functional inhibition assay, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (cytokine blockade, mAb functional inhibition) establishing regulatory feedback\",\n      \"pmids\": [\"19124726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NMR-based structural study of the DAP12-NKG2C transmembrane helix complex in explicit membranes revealed that five functionally required interfacial residues (two Asp and two Thr in DAP12 dimer, one Lys in NKG2C) form a stable network of salt bridges and hydrogen bonds; MD simulations refined side-chain arrangements consistent with available experimental constraints.\",\n      \"method\": \"NMR observable-based MD simulation in explicit micelles and bilayers, distance restraints\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — computational refinement of NMR structure, single study with simulation, no independent mutagenesis validation reported here\",\n      \"pmids\": [\"22500771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NKG2C zygosity (gene copy number) quantitatively influences CD94/NKG2C surface receptor levels, calcium influx signaling, degranulation, and IL-15-dependent proliferation upon receptor engagement, establishing a mechanistic link between KLRC2 copy number and receptor functional output in NK cells.\",\n      \"method\": \"Flow cytometry (surface levels, degranulation CD107a), intracellular calcium mobilization assay, proliferation assay, NKG2C genotyping in cohort\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays linking gene dose to receptor signaling, replicated across subjects\",\n      \"pmids\": [\"24030638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Expansion of NKG2C+ NK cells in response to HCMV requires both IL-12 from CD14+ inflammatory monocytes and the CD94/NKG2C/HLA-E axis: IL-12 neutralization substantially reduced NKG2C+ subset expansion and CD25 upregulation, while NKG2C blockade or HLA-E silencing in infected fibroblasts greatly impaired expansion.\",\n      \"method\": \"Co-culture system with HCMV-infected fibroblasts and monocytes, IL-12 neutralizing antibody, NKG2C-blocking mAb, HLA-E siRNA silencing, flow cytometry\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal interventions (cytokine neutralization, receptor blocking, ligand silencing) in same experimental system\",\n      \"pmids\": [\"25384219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HLA-E regulates NKG2C+ NK cell degranulation (CD107a) in a peptide-restricted manner: only 4 specific peptides (CMV-I, A80, B13, and HLA-G-derived) enhance NKG2C-mediated activation, and the HLA-E:G peptide complex triggers NKG2C receptor internalization reversible by bafilomycin.\",\n      \"method\": \"Degranulation assay (CD107a), flow cytometry, peptide-pulsed HLA-E target cells, bafilomycin treatment\",\n      \"journal\": \"Human immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with pharmacological validation, single lab\",\n      \"pmids\": [\"26382247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NKG2C-deficient (NKG2C−/−) humans still generate adaptive NK cells with characteristic footprints (terminally differentiated phenotype, epigenetic IFN-γ promoter remodeling, functional reprogramming); these adaptive NK cells express high CD2, which synergistically enhances ERK and S6RP phosphorylation after CD16 ligation and is critical for antibody-coated target cell responses.\",\n      \"method\": \"NK cell repertoire analysis in 60 NKG2C−/− donors, phospho-flow (ERK, S6RP), CD2 blocking/stimulation, ADCC assay, epigenetic methylation analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — natural human gene deletion model with multiple orthogonal functional methods and signaling assays\",\n      \"pmids\": [\"27117418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Activation of CD94/NKG2C by ligands displayed on HCMV-infected cells is dependent on viral strain: clinical isolates and endotheliotropic TB40/E strain (but not laboratory strains AD169/Towne) activate Jurkat-NKG2C+ reporter cells, and HLA-E+ 721.221 cells trigger NKG2C/DAP12-dependent NFAT/AP1 reporter activity antagonized by anti-NKG2C and anti-HLA-E mAbs.\",\n      \"method\": \"Jurkat reporter cell line expressing CD94/NKG2C/DAP12 with NFAT/AP1-luciferase reporter, antibody blocking, co-culture with HCMV-infected cells\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted reporter system with antibody blocking; single lab, viral strain dependency not fully resolved\",\n      \"pmids\": [\"29114247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NKG2C+ adaptive NK cells constitutively express HLA-DR and, after HCMV antigen loading via CD16 (accompanied by CD16 loss and CX3CR1 decrease), present HCMV antigens in an HLA-DR-dependent manner to CD28-negative effector-memory CD4+ T cells, inducing degranulation (CD107a) and Th1 cytokines (IFN-γ, TNF-α).\",\n      \"method\": \"Flow cytometry, HLA-DR blocking antibody, co-culture of HCMV-antigen-loaded NK cells with autologous CD4+ T cells, intracellular cytokine staining\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional antigen presentation assay with HLA-DR blocking, single lab\",\n      \"pmids\": [\"31001281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"NKG2C is expressed as a 36-kDa glycoprotein on NK cells; a soluble recombinant NKG2C protein binds specifically to K562 and RPMI 8866 cells (NK targets/feeders) but not to other hematopoietic lines, and binding structures disappear concomitant with loss of K562 susceptibility to killing upon differentiation induction.\",\n      \"method\": \"In vitro translation, recombinant protein expression, immunoprecipitation, soluble receptor binding assay, target cell differentiation\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — recombinant protein binding assay identifying target cell ligand, single lab\",\n      \"pmids\": [\"7589093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In γδ T cells, CD94/NKG2C associated with KARAP/DAP12 is fully functional (mediates IFN-γ production, proliferation, and cytolytic activity); when NKG2A and NKG2C are co-expressed on the same cell, the inhibitory signal from NKG2A prevails over NKG2C-mediated activation.\",\n      \"method\": \"IFN-γ ELISA, proliferation assay, cytolytic activity assay, functional co-expression experiments with NKG2A/NKG2C double-positive cells\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional readouts in primary γδ T cells, single lab\",\n      \"pmids\": [\"20952657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A distinct CD56hiCD161-CD8+ T-cell population in human liver sinusoids highly expresses NKG2C and exerts NKG2C-mediated NK-like effector functions (cytotoxicity, cytokine production) in the absence of TCR stimulation, activated by innate cytokines (IL-12/18, IL-15).\",\n      \"method\": \"CITE-seq with TCR-seq, flow cytometry, functional assays (TCR-independent NKG2C ligation), intrahepatic cell isolation\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — TCR-independent functional assay with NKG2C ligation, multi-omic characterization, single lab\",\n      \"pmids\": [\"35644434\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KLRC2 (NKG2C) encodes a C-type lectin-like type II transmembrane protein that heterodimerizes covalently with CD94 and non-covalently associates with the ITAM-bearing adaptor DAP12 via complementary charged transmembrane residues; the CD94/NKG2C complex binds HLA-E in a peptide-dependent manner with lower affinity than the inhibitory CD94/NKG2A, engages a mostly overlapping but partly distinct set of HLA-E residues, and upon ligation signals through DAP12-dependent MAPK/ERK activation and calcium mobilization to trigger NK (and T) cell cytotoxicity, cytokine production, and proliferation; KLRC2 copy number quantitatively modulates receptor surface density and downstream signaling strength, and HCMV-driven expansion of NKG2C+ adaptive NK cells requires both IL-12 from monocytes and the NKG2C/HLA-E axis, with CD2 providing co-stimulatory signal 2 when NKG2C is absent.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KLRC2 (NKG2C) encodes an activating C-type lectin-like receptor that heterodimerizes covalently with CD94 and associates non-covalently with the ITAM-bearing adaptor DAP12 through complementary charged transmembrane residues (Lys in NKG2C, Asp/Thr in DAP12), forming a trimolecular signaling complex on NK cells, γδ T cells, and subsets of CD8+ T cells [PMID:9655483, PMID:22500771, PMID:20952657]. The CD94/NKG2C complex recognizes HLA-E in a peptide-dependent manner with lower affinity and faster kinetics than the inhibitory CD94/NKG2A, engaging a largely overlapping but partly distinct set of HLA-E contact residues; upon ligation it signals through DAP12-dependent MAPK/ERK activation and calcium mobilization to trigger cytotoxicity, cytokine production (TNF-α, IFN-γ), and proliferation [PMID:10428963, PMID:14971033, PMID:11069065, PMID:9103421]. KLRC2 gene copy number quantitatively controls receptor surface density, calcium signaling magnitude, and degranulation capacity, and HCMV-driven expansion of NKG2C+ adaptive NK cells requires both monocyte-derived IL-12 and the NKG2C/HLA-E axis, with CD2 serving as an alternative co-stimulatory pathway when NKG2C is absent [PMID:24030638, PMID:25384219, PMID:27117418]. The KLRC2 locus undergoes homozygous deletion in approximately 4% of humans, yet NKG2C-deficient individuals can still generate adaptive NK cells with epigenetically reprogrammed IFN-γ loci, indicating functional redundancy in the adaptive NK cell differentiation program [PMID:14688071, PMID:27117418].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Initial identification of NKG2C as an NK cell surface glycoprotein whose soluble form binds NK target cells established it as a candidate recognition receptor, though its ligand and signaling mode were unknown.\",\n      \"evidence\": \"Recombinant soluble NKG2C binding assay on K562/RPMI 8866 target cells with differentiation controls\",\n      \"pmids\": [\"7589093\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ligand identity on target cells not determined\", \"Activating versus inhibitory function not resolved\", \"Single-lab observation without independent replication\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Chimeric receptor experiments resolved the key question of whether NKG2C delivers activating or inhibitory signals, demonstrating that NKG2C triggers cytotoxicity and calcium mobilization without recruiting the inhibitory phosphatase SHP-1.\",\n      \"evidence\": \"NKG2C/NKR-P1C chimeric receptors in RNK-16 cells; cytolytic assays, calcium flux, SHP-1 co-IP\",\n      \"pmids\": [\"9103421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling adaptor mediating activation not yet identified\", \"Physiological ligand still unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Two contemporaneous studies established the molecular architecture of the activating receptor complex: NKG2C covalently heterodimerizes with CD94 and non-covalently recruits the ITAM-bearing adaptor DAP12 via charge-complementary transmembrane residues, explaining how a receptor lacking intrinsic signaling motifs triggers activation.\",\n      \"evidence\": \"Co-IP, transmembrane mutagenesis, COS7 co-transfection, redirected killing assays\",\n      \"pmids\": [\"9655483\", \"9485212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural details of the DAP12–NKG2C transmembrane assembly not resolved\", \"Downstream signaling cascade not mapped\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of HLA-E as the ligand for CD94/NKG2C—and demonstration that NKG2C binds HLA-E with lower affinity and faster kinetics than inhibitory NKG2A—answered how activation and inhibition are balanced through a shared ligand with differential binding strength.\",\n      \"evidence\": \"Surface plasmon resonance with recombinant soluble CD94/NKG2C and peptide-loaded HLA-E; mouse Qa-1b binding with blocking mAb\",\n      \"pmids\": [\"10428963\", \"10601355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for affinity difference between NKG2C and NKG2A not determined\", \"Peptide selectivity of NKG2C recognition not fully characterized\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Reconstitution of the complete CD94/NKG2C/DAP12 complex in heterologous cells mapped the downstream signaling cascade to MAPK/ERK, showing that MEK inhibition blocks TNF-α production and cytotoxicity—establishing the first defined intracellular pathway downstream of NKG2C engagement.\",\n      \"evidence\": \"RBL cell transfection with CD94/NKG2C/DAP12; MAPK phosphorylation, calcium flux, serotonin release; MEK inhibitor PD098059\",\n      \"pmids\": [\"11069065\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of other signaling branches (PI3K, NF-κB) not addressed\", \"In vivo signaling relevance not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Alanine-scanning mutagenesis of HLA-E resolved how CD94/NKG2C and CD94/NKG2A discriminate the same ligand: they share most contact residues on the HLA-E α1/α2 platform, but two residues (D69, H155) are selectively required for NKG2A but not NKG2C binding, providing a structural explanation for differential affinity.\",\n      \"evidence\": \"Systematic alanine mutagenesis of HLA-E surface residues; binding analysis with soluble CD94/NKG2A and CD94/NKG2C\",\n      \"pmids\": [\"14971033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of CD94/NKG2C–HLA-E complex available\", \"Energetic contribution of each contact not quantified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that KLRC2 undergoes complete homozygous deletion in ~4% of humans (allele frequency ~20%) revealed that the gene is dispensable for survival and created a natural human knockout model for studying NKG2C function.\",\n      \"evidence\": \"PCR genotyping and breakpoint mapping in deletion versus wild-type haplotypes\",\n      \"pmids\": [\"14688071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of deletion for immune defense not yet assessed\", \"Selective pressure maintaining or driving deletion frequency unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extension of NKG2C function beyond NK cells: demonstration that CD94/NKG2C coupled to DAP12 on CD8+ T cells triggers cytotoxicity, cytokine release, and proliferation established NKG2C as an alternative activation pathway for adaptive lymphocytes.\",\n      \"evidence\": \"Co-IP of DAP12 via anti-CD94 in T cell clones; cytotoxicity, cytokine, and proliferation assays\",\n      \"pmids\": [\"15940674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Proportion and phenotype of NKG2C+ T cells in different tissues not systematically characterized\", \"TCR-independent versus TCR-dependent triggering not dissected\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery of a negative feedback loop: IL-12 transiently induces inhibitory NKG2A on NKG2C+ NK cells, dampening their HLA-E-mediated activation—establishing that NKG2A/NKG2C balance is dynamically regulated by cytokine milieu.\",\n      \"evidence\": \"IL-12 stimulation and anti-IL-12 blockade in co-culture with HCMV-infected DCs; anti-NKG2A functional inhibition\",\n      \"pmids\": [\"19124726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional mechanism of IL-12-driven NKG2A induction on NKG2C+ cells not identified\", \"Duration and reversibility of NKG2A co-expression in vivo unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"NMR-restrained MD simulations revealed the atomic-level arrangement of the DAP12–NKG2C transmembrane assembly: a salt-bridge/hydrogen-bond network involving two Asp and two Thr in the DAP12 dimer and one Lys in NKG2C stabilizes the complex within the membrane.\",\n      \"evidence\": \"NMR observable-based MD simulation in explicit micelles and lipid bilayers\",\n      \"pmids\": [\"22500771\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No independent mutagenesis validation of predicted contacts reported in this study\", \"Structure of the full ectodomain–transmembrane complex not resolved\", \"Computational model in micelles may not fully reflect native bilayer environment\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Gene dosage quantitatively controls NKG2C function: KLRC2 copy number determines receptor surface density, calcium signaling amplitude, degranulation efficiency, and IL-15-dependent proliferation, providing a mechanistic basis for population-level variation in NKG2C-dependent immune responses.\",\n      \"evidence\": \"Flow cytometry, calcium mobilization, CD107a degranulation, and proliferation assays stratified by NKG2C genotype across multiple donors\",\n      \"pmids\": [\"24030638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gene dose effects extend to in vivo viral control not tested\", \"Epigenetic regulation of KLRC2 expression beyond copy number not explored\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"HCMV-driven expansion of adaptive NKG2C+ NK cells was shown to require dual signals: monocyte-derived IL-12 and direct NKG2C/HLA-E engagement, with each independently necessary—resolving a long-standing question about the signals driving adaptive NK cell generation.\",\n      \"evidence\": \"Co-culture with HCMV-infected fibroblasts and monocytes; IL-12 neutralization, NKG2C blocking mAb, HLA-E siRNA silencing\",\n      \"pmids\": [\"25384219\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of other cytokines (IL-18, IL-15) as co-factors not fully dissected in this system\", \"Molecular mechanism linking HLA-E engagement to clonal expansion not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Analysis of NKG2C-null humans revealed functional redundancy in adaptive NK cell differentiation: NKG2C−/− individuals generate adaptive NK cells with characteristic epigenetic and phenotypic features, using CD2 as an alternative co-stimulatory receptor that synergistically enhances ERK/S6RP signaling after CD16 ligation.\",\n      \"evidence\": \"Repertoire analysis in 60 NKG2C−/− donors; phospho-flow for ERK/S6RP; CD2 blocking; ADCC assay; IFN-γ promoter methylation analysis\",\n      \"pmids\": [\"27117418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD2-dependent adaptive NK cells are functionally equivalent to NKG2C+ cells in viral control unknown\", \"Epigenetic mechanisms driving compensatory pathway engagement not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Viral strain specificity of NKG2C activation was established: clinical HCMV isolates and endotheliotropic TB40/E, but not laboratory strains AD169/Towne, activate CD94/NKG2C/DAP12-dependent NFAT/AP1 reporter signaling, suggesting that specific viral gene products or altered HLA-E peptide repertoires determine receptor engagement.\",\n      \"evidence\": \"Jurkat reporter cells expressing CD94/NKG2C/DAP12 with NFAT/AP1-luciferase; antibody blocking; co-culture with HCMV-infected cells\",\n      \"pmids\": [\"29114247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific viral gene or peptide responsible for strain-dependent activation not identified\", \"Reporter cell system may not fully recapitulate primary NK cell signaling thresholds\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NKG2C+ adaptive NK cells were shown to constitutively express HLA-DR and function as unconventional antigen-presenting cells, loading HCMV antigens via CD16 and presenting them to effector-memory CD4+ T cells—revealing an unanticipated bridge between innate and adaptive immunity.\",\n      \"evidence\": \"HLA-DR blocking antibody; co-culture of HCMV-antigen-loaded NK cells with autologous CD4+ T cells; intracellular cytokine staining\",\n      \"pmids\": [\"31001281\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of antigen processing and HLA-DR loading in NK cells not characterized\", \"In vivo relevance of NK cell antigen presentation not established\", \"Single-lab finding without independent replication\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of a liver-resident CD56hiCD161−CD8+ T cell population highly expressing NKG2C demonstrated tissue-specific innate-like T cell function driven by NKG2C ligation independently of TCR, expanding the functional scope of NKG2C to hepatic immunity.\",\n      \"evidence\": \"CITE-seq with TCR-seq, flow cytometry, TCR-independent NKG2C functional assays on intrahepatic cells\",\n      \"pmids\": [\"35644434\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ligand (HLA-E or other) driving NKG2C activation in liver sinusoidal environment not confirmed\", \"Contribution of this subset to liver disease or viral hepatitis defense unknown\", \"Single-cohort observation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the crystal structure of the CD94/NKG2C–HLA-E ternary complex, the specific HCMV-derived peptides or viral factors responsible for strain-dependent NKG2C activation, the transcriptional and epigenetic regulation of KLRC2 during adaptive NK cell differentiation, and the in vivo contribution of NKG2C signaling to HCMV control versus the compensatory CD2-dependent pathway.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of CD94/NKG2C–HLA-E complex\", \"Viral determinants of strain-specific NKG2C activation unidentified\", \"In vivo functional equivalence of NKG2C-dependent versus CD2-dependent adaptive NK pathways untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 2, 11, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 5, 8, 12, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 11, 15]}\n    ],\n    \"complexes\": [\n      \"CD94/NKG2C\",\n      \"CD94/NKG2C/DAP12\"\n    ],\n    \"partners\": [\n      \"CD94\",\n      \"DAP12\",\n      \"HLA-E\",\n      \"CD2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}